These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7698837)

  • 1. Ultrastructure of Borrelia burgdorferi after exposure to benzylpenicillin.
    Schaller M; Neubert U
    Infection; 1994; 22(6):401-6. PubMed ID: 7698837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis culture for determination of MIC and MBC of benzylpenicillin against Borrelia burgdorferi.
    Stiernstedt SH; Tadesse T; Wretlind B
    APMIS; 1999 Apr; 107(4):380-2. PubMed ID: 10230690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis culture enables more accurate determination of MIC of benzylpenicillin for Borrelia burgdorferi than does conventional procedure.
    Stiernstedt SH; Wretlind B
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2882-3. PubMed ID: 9124859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.
    Dever LL; Jorgensen JH; Barbour AG
    Antimicrob Agents Chemother; 1993 May; 37(5):1115-21. PubMed ID: 8517700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
    Baradaran-Dilmaghani R; Stanek G
    Infection; 1996; 24(1):60-3. PubMed ID: 8852472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium.
    Brorson O; Brorson SH
    Infection; 1998; 26(3):144-50. PubMed ID: 9646104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi.
    Kersten A; Poitschek C; Rauch S; Aberer E
    Antimicrob Agents Chemother; 1995 May; 39(5):1127-33. PubMed ID: 7625800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants.
    Mursic VP; Wanner G; Reinhardt S; Wilske B; Busch U; Marget W
    Infection; 1996; 24(3):218-26. PubMed ID: 8811359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of isolation rate of Borrelia burgdorferi sensu lato in MKP and BSK-II medium.
    Ruzić-Sabljić E; Lotric-Furlan S; Maraspin V; Cimperman J; Logar M; Jurca T; Strle F
    Int J Med Microbiol; 2006 May; 296 Suppl 40():267-73. PubMed ID: 16530005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
    Henneberg JP; Neubert U
    Orv Hetil; 2002 May; 143(21):1195-8. PubMed ID: 12073540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values.
    Boerner J; Failing K; Wittenbrink MM
    Zentralbl Bakteriol; 1995 Nov; 283(1):49-60. PubMed ID: 9810645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.
    Hunfeld KP; Ruzic-Sabljic E; Norris DE; Kraiczy P; Strle F
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1294-301. PubMed ID: 15793100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
    Preac Mursic V; Marget W; Busch U; Pleterski Rigler D; Hagl S
    Infection; 1996; 24(1):9-16. PubMed ID: 8852456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roxithromycin in the treatment of Lyme disease--update and perspectives.
    Gasser R; Wendelin I; Reisinger E; Bergloff J; Feigl B; Schafhalter I; Eber B; Grisold M; Klein W
    Infection; 1995; 23 Suppl 1():S39-43. PubMed ID: 7782115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of isolation rate of Borrelia burgdorferi sensu lato in two different culture media, MKP and BSK-H.
    Ružić-Sabljić E; Maraspin V; Cimperman J; Strle F; Lotrič-Furlan S; Stupica D; Cerar T
    Clin Microbiol Infect; 2014 Jul; 20(7):636-41. PubMed ID: 24237688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
    Rödel R; Freyer A; Bittner T; Schäfer V; Hunfeld KP
    Int J Antimicrob Agents; 2007 Jul; 30(1):83-6. PubMed ID: 17512703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole.
    Brorson O; Brorson SH
    APMIS; 1999 Jun; 107(6):566-76. PubMed ID: 10379684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
    Dever LL; Jorgensen JH; Barbour AG
    J Clin Microbiol; 1992 Oct; 30(10):2692-7. PubMed ID: 1400969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of penicillin G and amoxicillin against 14 strains of Streptococcus milleri].
    Berardi-Grassias L; Le Pennec MP; Chauvière P
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):632-4. PubMed ID: 3054739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and genotyping of Borrelia burgdorferi sensu lato by polymerase chain reaction.
    Situm M; Grahovac B; Marković S; Lipozencić J; Poje G; Dobrić I; Marinović B; Bolanca-Bumber S; Misić-Majerus L
    Croat Med J; 2000 Mar; 41(1):47-53. PubMed ID: 10810167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.